BioCentury
ARTICLE | Company News

Chinese Academy of Sciences, MicroConstants China deal

February 9, 2015 8:00 AM UTC

MicroConstants received worldwide rights from the academy’s Institute of Biophysics to develop and commercialize antibody AA98 to treat cancer, multiple sclerosis (MS) and age-related macular degener...